Karen J Parker

Title: Karen J Parker: Innovator in Autism Treatment

Introduction

Karen J Parker is a notable inventor based in Stanford, California. She has made significant contributions to the field of autism treatment through her innovative research and patent. Her work focuses on addressing social deficits associated with autism spectrum disorder (ASD).

Latest Patents

Karen J Parker holds a patent for her invention titled "Intranasal vasopressin treatment of social deficits in autism." This patent outlines methods for treating, reducing, and ameliorating symptoms of ASD in subjects. The treatment involves intranasally administering arginine vasopressin (AVP) or an analog of vasopressin to children aged between 6 and 12 years. The patent highlights the surprising effectiveness of AVP treatment in children with high pre-treatment blood levels of AVP.

Career Highlights

Karen J Parker is affiliated with Leland Stanford Junior University, where she conducts her research. Her work has garnered attention for its potential to improve the lives of children with autism. The innovative approach she has developed represents a significant advancement in the treatment of social impairments associated with ASD.

Collaborations

Karen has collaborated with esteemed colleagues, including Antonio Y Hardan and Dean Carson. These collaborations have further enriched her research and contributed to the development of effective treatment methods.

Conclusion

Karen J Parker's contributions to autism treatment through her innovative patent demonstrate her commitment to improving the lives of those affected by ASD. Her work continues to inspire advancements in the field of mental health and treatment methodologies.